You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 1, January 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, NEW ORLEANS, MAY 22 TO MAY 25, 1988-Pa rt I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (70)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Implications of Accurate Pathologic Margins in the Treatment of Primary Breast Cancer

Thomas G. Frazier, MD; Randolph W. Y. Wong, MD; David Rose, MD

Arch Surg. 1989;124(1):37-38.


Abstract

• Eighty-seven patients who underwent mastectomy or reexcision following a previous segmental resection with pathologic margins evaluated at that time were restudied following their definitive therapy. Of these, 40 (46.0%) had involved margins, 28 (32.2%) had close margins, and 19 (21.8%) had clear margins. Residual tumor was subsequently found in 21 (52.5%) of 40, nine (32.1%) of 28, and five (26.3%) of 19, respectively. Analysis of specimens for quadrant of residual tumor showed 27 (31.0%) of 87 patients in the same quadrant, and 11(14.7%) of 75 present in a different quadrant. The assessment of microscopic margins may be misleading since 29.8% (14/47) of patients with clear or close margins subsequently had residual tumor, and 47.5% (19/40) of those with involved margins had no residual tumor found. Further studies are essential to define the optimum guidelines for tumor excision at the time of segmental resection.

(Arch Surg 1989;124:37-38)



Author Affiliations

From the Department of Surgery, Bryn Mawr Hospital, Pa (Drs Frazier and Rose), and the Department of Surgery, Thomas Jefferson University, Philadelphia (Drs Frazier, Wong, and Rose). Dr Wong is now with the Department of Surgery, University of Arizona, Tucson.


Footnotes

Accepted for publication Sept 2, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 23, 1988.

Reprint requests to 600 Haverford Rd, Haverford, PA 19041 (Dr Frazier).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Improved Processing Method for Breast Whole-Mount Serial Sections for Three-Dimensional Histopathology Imaging
Sun et al.
Am J Clin Pathol 2009;131:383-392.
ABSTRACT | FULL TEXT  

Percutaneous Removal of Postbiopsy Marking Clip in the Breast Using Stereotactic Technique
Brenner
Am. J. Roentgenol. 2001;176:417-419.
FULL TEXT  

Planned Segmentectomy: A Necessity for Breast Carcinoma
Tafra et al.
Arch Surg 1993;128:1014-1020.
ABSTRACT  

Breast Cancer: Importance of Adequate Surgical Excision Prior to Radiotherapy in the Local Control of Breast Cancer in Patients Treated Conservatively
Ghossein et al.
Arch Surg 1992;127:411-415.
ABSTRACT  

Breast Biopsy Techniques and Adequacy of Margins
Ngai et al.
Arch Surg 1991;126:1343-1347.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.